Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Net Income towards Common Stockholders (2016 - 2025)

Nutex Health's Net Income towards Common Stockholders history spans 14 years, with the latest figure at $16.6 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 83.31% year-over-year to $16.6 million; the TTM value through Dec 2025 reached $151.1 million, up 59.08%, while the annual FY2025 figure was $180.4 million, 245.65% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $16.6 million at Nutex Health, down from $103.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $128.9 million in Q4 2021 and bottomed at -$422.5 million in Q3 2022.
  • The 5-year median for Net Income towards Common Stockholders is $5.1 million (2022), against an average of -$1.0 million.
  • The largest YoY upside for Net Income towards Common Stockholders was 10331.54% in 2021 against a maximum downside of 11080.72% in 2021.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $128.9 million in 2021, then crashed by 92.29% to $9.9 million in 2022, then crashed by 379.08% to -$27.7 million in 2023, then soared by 459.07% to $99.5 million in 2024, then plummeted by 83.31% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Net Income towards Common Stockholders are $16.6 million (Q4 2025), $103.4 million (Q3 2025), and $16.1 million (Q2 2025).